Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01882257 · ClinicalTrials.gov registry record · NA
Home-Based Diagnosis and Management of Sleep-Related Breathing Disorders in Spinal Cord Injury
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT01882257 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 93 participants.
The verdict
NCT01882257, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
* Patients with spinal cord injury (SCI) usually breathe without any mechanical assistance, but significant breathing problems occur often during sleep, either because the upper airway closes (obstructive sleep apnea; OSA), or because of weakness/paralysis of the breathing muscles. These problems often go unrecognized, as SCI patients face logistical barriers that cause them to refuse appropriate testing in sleep laboratories. We have devised a strategy for diagnosing sleep-disordered breathing in the patient's home, using placement of noninvasive devices that monitor breathing overnight. This project is designed to test the feasibility and utility of this strategy. * After collecting baseline data on symptoms and medical events for four months, the home-based studies are performed noninvasively with FDA-approved devices: a type III sleep system and a recording oxygen saturation/ transcutaneous carbon dioxide monitor. If these studies identify sleep-disordered breathing, noninvasive ventilatory support is prescribed according to standard clinical practice. Over the following twelve months, the subjects monitor their symptoms daily, and answer quality-of-life questionnaires every three months. After 3, 6, and 12 months, blood tests are performed to measure blood sugar and cholesterol/lipids. Data is downloaded from the ventilator device to monitor compliance and ventilator performance. This study is designed to determine the prevalence of sleep-disordered breathing in SCI, the feasibility of home-based testing to establish the diagnosis, and the short term effects on symptoms, quality-of-life, and associated conditions (glucose intolerance, blood lipid disorders).
Interventions
- DEVICE BiPAP
- DEVICE BiPAP/AVAPS (Phillips Respironics)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2011-10 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01882257
The ClinicalTrials.gov registry entry for NCT01882257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BiPAP is the first listed.
NCT01882257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01882257 about?
NCT01882257 is a clinical study titled "Home-Based Diagnosis and Management of Sleep-Related Breathing Disorders in Spinal Cord Injury". * Patients with spinal cord injury (SCI) usually breathe without any mechanical assistance, but significant breathing problems occur often during sleep, either because the upper airway closes (obstructive sleep apnea; OSA), or because of weakness/paralysis of the breathing muscles. These problems of...
What is the current status of trial NCT01882257?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2011-10. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01882257?
The interventions under investigation include: BiPAP (DEVICE), BiPAP/AVAPS (Phillips Respironics) (DEVICE).
Who is sponsoring clinical trial NCT01882257?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.